Blocking sphingosine 1-phosphate receptor 2 accelerates hepatocellular carcinoma progression in a mouse model of NASH.
暂无分享,去创建一个
S. Terai | M. Takamura | T. Suganami | Y. Ogawa | A. Tsuchiya | S. Nojiri | M. Ogawa | M. Itoh | Takayuki Watanabe | Tomoaki Yoshida | S. Takeuchi | Masaru Kumagai | Suguru Takeuchi | Michiko Itoh
[1] Masato Tanaka,et al. CD11c+ resident macrophages drive hepatocyte death-triggered liver fibrosis in a murine model of nonalcoholic steatohepatitis. , 2017, JCI insight.
[2] S. Pyne,et al. Sphingosine 1-phosphate and cancer. , 2017, Advances in biological regulation.
[3] J. González‐Gallego,et al. Sphingosine 1-Phosphate Signaling as a Target in Hepatic Fibrosis Therapy , 2017, Front. Pharmacol..
[4] M. Maceyka,et al. Sphingosine kinase and sphingosine-1-phosphate in liver pathobiology , 2017, Critical reviews in biochemistry and molecular biology.
[5] Lixin Sun,et al. The role of sphingosine 1‐phosphate receptor 2 in bile‐acid–induced cholangiocyte proliferation and cholestasis‐induced liver injury in mice , 2017, Hepatology.
[6] K. Tsuchiya,et al. Antifibrotic effect of pirfenidone in a mouse model of human nonalcoholic steatohepatitis , 2017, Scientific Reports.
[7] V. Shah,et al. Inhibition of sphingosine 1-phosphate signaling ameliorates murine nonalcoholic steatohepatitis. , 2017, American journal of physiology. Gastrointestinal and liver physiology.
[8] L. Henry,et al. Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes , 2016, Hepatology.
[9] D. Mukhopadhyay,et al. Exosome Adherence and Internalization by Hepatic Stellate Cells Triggers Sphingosine 1-Phosphate-dependent Migration* , 2015, The Journal of Biological Chemistry.
[10] N. Ohkohchi,et al. Sphingosine 1‐phosphate has anti‐apoptotic effect on liver sinusoidal endothelial cells and proliferative effect on hepatocytes in a paracrine manner in human , 2015, Hepatology research : the official journal of the Japan Society of Hepatology.
[11] S. Spiegel,et al. Conjugated bile acid–activated S1P receptor 2 is a key regulator of sphingosine kinase 2 and hepatic gene expression , 2015, Hepatology.
[12] J. Kornhuber,et al. Serum acid sphingomyelinase is upregulated in chronic hepatitis C infection and non alcoholic fatty liver disease. , 2014, Biochimica et biophysica acta.
[13] S. Terai,et al. Hepatic Crown-Like Structure: A Unique Histological Feature in Non-Alcoholic Steatohepatitis in Mice and Humans , 2013, PloS one.
[14] Y. Hannun,et al. Sphingosine‐1‐phosphate receptor 2 , 2013, The FEBS journal.
[15] Shelly C. Lu,et al. Excess S‐adenosylmethionine reroutes phosphatidylethanolamine towards phosphatidylcholine and triglyceride synthesis , 2013, Hepatology.
[16] S. Terai,et al. Melanocortin 4 receptor-deficient mice as a novel mouse model of nonalcoholic steatohepatitis. , 2011, The American journal of pathology.
[17] Shelly C. Lu,et al. Loss of the glycine N‐methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice , 2007, Hepatology.
[18] Masafumi Takahashi,et al. Sphingosine-1-phosphate receptor agonists suppress concanavalin A-induced hepatic injury in mice. , 2006, Biochemical and biophysical research communications.
[19] R. Schwabe,et al. Roles for C16-ceramide and Sphingosine 1-Phosphate in Regulating Hepatocyte Apoptosis in Response to Tumor Necrosis Factor-α* , 2005, Journal of Biological Chemistry.
[20] T. Hla,et al. Signaling of sphingosine-1-phosphate via the S1P/EDG-family of G-protein-coupled receptors. , 2002, Biochimica et biophysica acta.
[21] B. Friedman,et al. Selective Loss of Sphingosine 1-Phosphate Signaling with No Obvious Phenotypic Abnormality in Mice Lacking Its G Protein-coupled Receptor, LPB3/EDG-3* , 2001, The Journal of Biological Chemistry.
[22] A. Sanyal,et al. A Lipidomic Readout of Disease Progression in A Diet-Induced Mouse Model of Nonalcoholic Fatty Liver Disease. , 2015, Transactions of the American Clinical and Climatological Association.